Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. Digital Camcorders
  10. 10. GPS
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Forest Laboratories Inc.



Sort by : relevance - date - popularity
3Vote!

Forest Laboratories Presents Analysis Of Two Positive Pivotal Phase III Studies Of Ceftaroline For The Treatment Of Community-Acquired Pneumonia (CAP)

Forest Laboratories, Inc (NYSE: FRX) presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftaroline for the treatment of community-acquired pneumonia (CAP) in hospitalized patients.

4Vote!

Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC

SAN FRANCISCO - Forest Laboratories, Inc (NYSE: FRX) today presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftarol

5Vote!

Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC

SAN FRANCISCO--(BUSINESS WIRE)--Forest Laboratories, Inc (NYSE: FRX) today presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftaroline for the treatment of community-acquired pneumonia (CAP) in hospitalized patients. Detailed analyses...

6Vote!

Forest Laboratories, AstraZeneca sign partnership

Forest Laboratories Inc. and AstraZeneca said Wednesday they are collaborating to develop and sell a next-generation treatment for antibiotic-resistant, or Staph, infections and hospital-acquired pneumonia.

4Vote!

Edward Owens Buys Energizer Holdings Inc., Cardinal Health Inc. ...

Edward Owens is probably one of the best investors in healthcare, a most debated industry these days. Many of our gurus are moving money into healthcare. What are the best healthcare investments? Take a look at Edward Owens ' portfolio. This is the Q2 portfolio update of Edward Owens . Edward Owens buys UCB S A, Energizer Holdings Inc. during the 3-months ended 06/30/2009, according to the most recent...

4Vote!

David Dreman Buys Microsemi Corp., Anworth Mortgage Asset Corp. ...

David Dreman , the renowned contrarian investor, had a forgetable 2008. His idea is "that we accumulate useful resources, such as crude for our strategic oil reserve. This would create new jobs, halt a deflationary spiral and give us some protection against the next international oil crisis." David Dreman owns 297 stocks with a total value of $3.1 billion. This is his Q2 portfolio update....

4Vote!

Forest Lab earnings rise to 87 cents a share

NEW YORK (MarketWatch) -- Forest Laboratories Inc. said Tuesday that fiscal first-quarter earnings were $263 million, or 87 cents a share, compared to $243 million, or 79 cents a share in the same period a year ago. Revenue grew 4.3% to $1 billion from $967 million. Analysts polled by FactSet Research estimated, on average, earnings per share of 82 cents and sales of $1 billion. Market Pulse Stories...

4Vote!

AC Financial: AnalystChoice.com Brings You the Best Complimentary Research Report on FRX, CF, LOW, STT, AIZ and DPS

NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Forest Laboratories Inc. (NYSE: FRX), CF Industries Holdings Inc. (NYSE: CF), Lowe's Companies Inc. (NYSE: LOW), State...

3Vote!

Stock Alerts on Monday's Market Movers: FRX, HRS, PM, IAG, STLD, WYN

(EMAILWIRE.COM, June 23, 2009 ) DALLAS, Texas – Beacon Equity Research announces the release of stock alerts covering Monday's market movers: Forest Laboratories Inc. (NYSE: FRX), Harris Corp. (NYSE: HRS), Philip Morris International Inc. (NYSE: PM), IAMGOLD Corp. (NYSE: IAG), Steel Dynamics Inc....

4Vote!

WallStSense.com: WallStSense.com Free Research Report for Shareholders of FRX, GD, GES and GT

NEW DELHI, INDIA (MARKET WIRE) W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued free ratings reports on the following four companies: Forest Laboratories Inc. (NYSE: FRX), General Dynamics Corporation (NYSE: GD), Guess? Inc. (NYSE: GES) and The Goodyear Tire & Rubber Company (NYSE: GT).

4Vote!

Zacks Analyst Blog Highlights: Cypress Bioscience, Inc., Forest Laboratories, Inc., Allied Irish Banks, p.l.c., Baxter International and Pfizer

CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

3Vote!

Lexapro Loses First-Line Position For The Treatment Of Major Depression

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Forest Laboratories' Lexapro is no longer the leading first-line agent of choice for the treatment of major depression.

3Vote!

Fairholme Fund Q1 Results Dragged by Pfizer and Forest Laboratories, Inc.

It has been a rough year for value investors. Bruce Berkowitz , the favorite guru of many of our users, lost 36% with his Fairholme Fund. Pfizer ( PFE), 16% of fund and his largest holding by far, was not helping. Bruce Berkowitz is heavily invested health care, including pharmaceuticals like Pfizer, Inc., and Forest Laboratories, Inc., and healthcare managers WellPoint, Inc., and UnitedHealth Group,...

4Vote!

Zacks Analyst Blog Highlights: UTX Corp., Comerica Inc., Brinker International, Regions Financial Corp. and Forest Laboratories, Inc.

CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

5Vote!

Forest Lab Profit Plunges on Charges

Forest Laboratories suffered a nearly 50% drop in profit due to charges related to a federal investigation.